| Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma M Kang, C Park, SH Kim, SW Yoon, KJ Suh, YJ Kim, CY Ock, M Kim, ... Translational Lung Cancer Research 10 (2), 699, 2021 | 16 | 2021 |
| Pneumocystis jirovecii pneumonia in diffuse large B‐cell Lymphoma treated with R‐CHOP JY Lee, M Kang, KJ Suh, JW Kim, SH Kim, JW Kim, YJ Kim, KH Song, ... Mycoses 64 (1), 60-65, 2021 | 9 | 2021 |
| AZD8186 in combination with paclitaxel in patients with advanced gastric cancer: results from a phase Ib/II study (KCSG ST18-20) KJ Suh, MH Ryu, DY Zang, WK Bae, HS Lee, HJ Oh, M Kang, JW Kim, ... The Oncologist 28 (9), e823-e834, 2023 | 5 | 2023 |
| Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors M Kang, HY Na, S Ahn, JW Kim, S Lee, S Ahn, JH Lee, J Youk, HT Kim, ... Elife 11, e78636, 2022 | 5 | 2022 |
| Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study M Kang, KJ Suh, JW Kim, JM Byun, JW Kim, JY Lee, JO Lee, SM Bang, ... PLoS One 17 (1), e0261671, 2022 | 4 | 2022 |
| Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis S Oh, SK Nam, KW Lee, HS Lee, Y Park, Y Kwak, KS Lee, JW Kim, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2024 | 1 | 2024 |
| Longitudinal comparative analysis of circulating tumor DNA and matched tumor tissue DNA in patients with metastatic colorectal cancer receiving palliative first-line systemic … S Lee, JW Kim, HG Kim, SH Hwang, KJ Kim, JH Lee, J Seo, M Kang, ... Cancer Research and Treatment, 2024 | | 2024 |
| Association of artificial intelligence (AI)-based HER2 scoring with clinical outcomes to first-line trastuzumab plus chemotherapy in HER2-positive metastatic gastric cancer (mGC) M Kang, Y Lim, HJ Oh, JA Lee, JW Kim, JW Kim, S Song, H Song, KW Lee Cancer Research 84 (6_Supplement), 2484-2484, 2024 | | 2024 |
| Pairwise analysis of plasma cell-free DNA before and after paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer JW Kim, DS Kyung, WY Ko, HP Kim, SH Hwang, KJ Kim, JH Lee, J Seo, ... Cancer Research 84 (6_Supplement), 2425-2425, 2024 | | 2024 |
| Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG … SH Lim, KW Lee, JJ Kim, HS Im, IH Kim, HS Han, DH Koo, JH Cho, ... BMC cancer 24 (1), 252, 2024 | | 2024 |
| Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer Y Lim, S Choi, HJ Oh, C Kim, S Song, S Kim, H Song, S Park, JW Kim, ... NPJ Precision Oncology 7 (1), 124, 2023 | | 2023 |
| Incidence and risk factors of skeletal-related events in patients with multiple myeloma: A population-based study of Korea JY Lee, JH Lee, M Kang, EH Jung, SA Kim, KJ Suh, JW Kim, SH Kim, ... | | 2023 |
| The correlation between single nucleotide polymorphism of chemokine receptor and ligand and infiltrating immune cells on tumor microenvironment of gastric cancer S Yoon, JH Lee, M Kang, HJ Oh, J Koh, HS Lee, SH Kang, YS Park, ... Cancer Research 83 (7_Supplement), 5951-5951, 2023 | | 2023 |
| Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of prognosis in stage II-III resectable colon cancer. Y Lim, S Choi, HJ Oh, S Song, S Kim, H Song, S Park, JW Kim, JW Kim, ... Journal of Clinical Oncology 41 (4_suppl), 211-211, 2023 | | 2023 |
| Incidence of Skeletal-Related Events Among Multiple Myeloma Patients: A Nationwide Population-Based Cohort Study JY Lee, JH Lee, SA Kim, KJ Suh, JW Kim, SH Kim, JO Lee, JW Kim, ... Blood 140 (Supplement 1), 12570-12570, 2022 | | 2022 |
| Evolutionary trajectories during carcinogenesis and metastasis in gallbladder adenocarcinoma M Kang, HY Na, S Ahn, JW Kim, S Lee, S Ahn, JH Lee, J Youk, HT Kim, ... Cancer Research 82 (12_Supplement), 6083-6083, 2022 | | 2022 |
